Kathy Steece‐Collier

Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

Katrina L. Paumier, Kelvin C. Luk, Fredric P. Manfredsson et al. · Neurobiology of Disease · 2015 · 387 citations · Full text

Neurodegenerative Diseases, Experimental Neuropathology, Bilateral Nigrostriatal Degeneration +7

Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat

Jeffrey H. Kordower, Hemraj B. Dodiya, Adam M. Kordower et al. · Neurobiology of Disease · 2011 · 156 citations · Full text

Neurodegenerative Diseases, Dopaminergic Neurons, Neurology +5

Antiparkinsonian Actions of CP-101,606, an Antagonist of NR2B Subunit-Containing N-Methyl-d-Aspartate Receptors

Kathy Steece‐Collier, Leslie K. Chambers, Sarah Jaw‐Tsai et al. · Experimental Neurology · 2000 · 136 citations

Biochemistry, Functional Selectivity, Medicine +7

Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss

Anne L. Spieles-Engemann, Michael M. Behbehani, Timothy J. Collier et al. · Neurobiology of Disease · 2010 · 133 citations · Full text

Health Sciences, Neurophysiology, Neuroanatomy +12

α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease

Tracy Cole, Hien Zhao, Timothy J. Collier et al. · JCI Insight · 2021 · 126 citations · Full text

Neurogenomics, α-Synuclein Antisense Oligonucleotides, Snca Asos +24